Brief introduction explaining scope and methodology.
#1
Rochester, Minnesota
#2
Cleveland, Ohio
#3
St. Louis, Missouri
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026
Insights from the Clareon® Summit Experience 2026, highlight how surgeons are looking to the underlying science to choose an IOL option that best matches their patient’s needs
June 3, 2026
Moorfields and UCL launch dataset aiming to accelerate research into anterior segment conditions
July 16, 2026
